Clinical Studies
Dasher Neuroscience is dedicated to advancing CNS health, and we deeply thank all patients, healthy volunteers, families, and clinical sites who participate in our clinical trials.
Current Clinical Trials and Study Phases
| Program | Indication | Phase | Status | See details |
|---|---|---|---|---|
| YA-101 | Multiple System Atrophy | Phase 2 | Enrolling | ClinicalTrials.gov |
| A Double-Blind, Placebo-Controlled, Multi-Center, Phase II, Dose Escalation Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Efficacy of YA-101 in Subjects With Multiple System Atrophy | ||||